ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation

Ann Hematol. 2011 Aug;90(8):971-3. doi: 10.1007/s00277-010-1107-x. Epub 2010 Nov 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Hematopoietic Stem Cell Transplantation
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / therapy
  • Humans
  • Lenalidomide
  • Prednisone / administration & dosage
  • Recurrence
  • Remission Induction
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives*
  • Transplantation, Autologous

Substances

  • Cytarabine
  • Thalidomide
  • Etoposide
  • Lenalidomide
  • Cisplatin
  • Prednisone

Supplementary concepts

  • ESHAP regimen